Magnetic resonance outcome of new enhancing lesions in patients with relapsing-remitting multiple sclerosis

Olga Ciccarelli, Elisabetta Giugni, Andrea Paolillo, Caterina Mainero, Claudio Gasperini, Stefano Bastianello, Carlo Pozzilli

Research output: Contribution to journalArticle

Abstract

The aim of the study was to monitor the natural history of new enhancing lesions in multiple sclerosis (MS) by means of serial gadolinium-enhanced magnetic resonance imaging (MRI). Out of the 63 new enhancing lesions seen on the baseline scan, belonging to 26 relapsing-remitting MS patients, 26 (40%), nine (14%) and four (6%) lesions showed persisting enhancement at first, second and third follow-up scan, respectively. At the end of 5 months of follow-up, 58 (92%) of the new enhancing lesions were detected as T2 hyperintensities, 24 (38%) as T1 hypointensities ('black holes'), and five lesions (8%) disappeared in both T2 and T1 weighted images. Duration of gadolinium enhancement of at least two consecutive scans significantly influenced the development of 'black holes'. No significant correlation was observed between volume, location, configuration of enhancement at baseline and final outcome of the lesion. In individual cases, different evolution of new enhancing lesions was observed at the same time. In conclusion, this study documented that different outcomes of new lesions are unrelated either to the individual patient or to the baseline MRI characteristics. However, prolonged blood-brain-barrier disruption as shown by persisting enhancement significantly influences the lesion outcome.

Original languageEnglish
Pages (from-to)455-459
Number of pages5
JournalEuropean Journal of Neurology
Volume6
Issue number4
Publication statusPublished - 1999

Keywords

  • Gadolinium enhancement
  • Magnetic resonance imaging
  • Multiple sclerosis
  • Natural history

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Fingerprint Dive into the research topics of 'Magnetic resonance outcome of new enhancing lesions in patients with relapsing-remitting multiple sclerosis'. Together they form a unique fingerprint.

  • Cite this

    Ciccarelli, O., Giugni, E., Paolillo, A., Mainero, C., Gasperini, C., Bastianello, S., & Pozzilli, C. (1999). Magnetic resonance outcome of new enhancing lesions in patients with relapsing-remitting multiple sclerosis. European Journal of Neurology, 6(4), 455-459.